Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity | Patent Application Number 13509626

13509626
Not Appealed
Patent NumberUS 09061029 B2
Publication NumberUS 20120289528 A1
Filled DateNov 17, 2010
Priority DateNov 17, 2009
Inventor/ApplicantsOphelia Yin
Neil Gallagher
ExaminesHENLEY III, RAYMOND J
Art Unit1629
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.